Literature DB >> 16304202

Levofloxacin and moxifloxacin increase human gut colonization by Candida species.

George Samonis, Diamantis P Kofteridis, Sofia Maraki, Dimitrios Alegakis, Elpis Mantadakis, John A Papadakis, Achilleas H Gikas, Matthew E Falagas, Matthew Falagas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16304202      PMCID： PMC1315982          DOI： 10.1128/AAC.49.12.5189.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  6 in total

Review 1.  Gut flora in health and disease.

Authors:  Francisco Guarner; Juan-R Malagelada
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

Review 2.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

3.  The impact of norfloxacin, ciprofloxacin and ofloxacin on human gut colonization by Candida albicans.

Authors:  E Mavromanolakis; S Maraki; A Cranidis; Y Tselentis; D P Kontoyiannis; G Samonis
Journal:  Scand J Infect Dis       Date:  2001

4.  Risk factors for hospital-acquired candidemia. A matched case-control study.

Authors:  S B Wey; M Mori; M A Pfaller; R F Woolson; R P Wenzel
Journal:  Arch Intern Med       Date:  1989-10

5.  Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.

Authors:  G Samonis; A Gikas; P Toloudis; S Maraki; G Vrentzos; Y Tselentis; N Tsaparas; G Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

6.  Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.

Authors:  B E Scully; K Jules; N X Chin; H C Neu
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965
  6 in total
  10 in total

1.  The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

Authors:  Ashwini Jadhav; Bhagyashree Bansode; Datta Phule; Amruta Shelar; Rajendra Patil; Wasudev Gade; Kiran Kharat; Sankunny Mohan Karuppayil
Journal:  World J Microbiol Biotechnol       Date:  2017-04-13       Impact factor: 3.312

2.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

Review 3.  Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia.

Authors:  Armin Rashidi; Daniel J Weisdorf
Journal:  Transl Res       Date:  2020-04-05       Impact factor: 7.012

Review 4.  Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis.

Authors:  Panomwat Amornphimoltham; Peter S T Yuen; Robert A Star; Asada Leelahavanichkul
Journal:  Dig Dis Sci       Date:  2019-03-13       Impact factor: 3.199

5.  Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype.

Authors:  Kathleen Romanowski; Alexander Zaborin; Vesta Valuckaite; Ronda J Rolfes; Trissa Babrowski; Cindy Bethel; Andrea Olivas; Olga Zaborina; John C Alverdy
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

Review 6.  Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease.

Authors:  Malcolm A Finkelman
Journal:  J Fungi (Basel)       Date:  2020-12-29

Review 7.  Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.

Authors:  Md Rayhan Mahmud; Sharmin Akter; Sanjida Khanam Tamanna; Lincon Mazumder; Israt Zahan Esti; Sanchita Banerjee; Sumona Akter; Md Rakibul Hasan; Mrityunjoy Acharjee; Md Sajjad Hossain; Anna Maria Pirttilä
Journal:  Gut Microbes       Date:  2022 Jan-Dec

8.  Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach.

Authors:  Buvaneswari Shanmugham; Archana Pan
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  A cluster of Candida krusei infections in a haematological unit.

Authors:  Timo Hautala; Irma Ikäheimo; Heidi Husu; Marjaana Säily; Timo Siitonen; Pirjo Koistinen; Jaana Vuopio-Varkila; Markku Koskela; Pekka Kujala
Journal:  BMC Infect Dis       Date:  2007-08-22       Impact factor: 3.090

10.  Plasma 1,3-β-d-glucan levels predict adverse clinical outcomes in critical illness.

Authors:  Georgios D Kitsios; Daniel Kotok; Haopu Yang; Malcolm A Finkelman; Yonglong Zhang; Noel Britton; Xiaoyun Li; Marina S Levochkina; Amy K Wagner; Caitlin Schaefer; John J Villandre; Rui Guo; John W Evankovich; William Bain; Faraaz Shah; Yingze Zhang; Barbara A Methé; Panayiotis V Benos; Bryan J McVerry; Alison Morris
Journal:  JCI Insight       Date:  2021-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.